Expression of MDR1, MRP2 and BCRP mRNA in tissues of turkeys

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 4, 2008, Pages 378-385

  Haritova, A M ^a   Schrickx, J ^b   Lashev, L D ^a   Fink Gremmels, J ^b  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; DANOFLOXACIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TRACT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA TRANSCRIPTION; TISSUE DISTRIBUTION; TURKEY (BIRD);

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; FLUOROQUINOLONES; HALF-LIFE; MALE; METABOLIC CLEARANCE RATE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; RNA, MESSENGER; TISSUE DISTRIBUTION; TURKEYS;

EID: 47349128048     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00968.x     Document Type: Article

References (56)

1. Allen, J.D. Schinkel, A.H. (2002) Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2). Molecular Cancer Therapeutics, 1, 427 434.
2. Alvarez, A.I., Perez, M., Prieto, J.G., Molina, A.J., Real, R. Merino, G. (2008) Fluoroquinolone efflux mediated by ABC transporters. Journal of Pharmaceutical Sciences. DOI
3. Barnes, D.M. (2001) Expression of P-glycoprotein in the chicken. Comparative Biochemistry and Physiology. Part A, Molecular and Integrative Physiology, 130, 301 310.
4. Brady, J.M., Cherrington, N.J., Hartley, D.P., Buist, S.C., Li, N. Klaassen, C.D. (2002) Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metabolism and Disposition, 30, 838 844.
5. Cascorbi, I. (2006) Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacology & Therapeutics, 112, 457 473.
6. Cherrington, N.J., Hartley, D.P., Li, N., Johnson, D.R. Klaassen, C.D. (2002) Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. The Journal of Pharmacology and Experimental Therapeutics, 300, 97 104.
7. Choudhuri, S., Cherrington, N.J., Li, N. Klaassen, C.D. (2003) Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metabolism and Disposition, 31, 1337 1345.
8. Collett, A., Tanianis-Hughes, J. Warhurst, G. (2004) Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions? Biochemical Pharmacology, 68, 783 790.
9. Conrad, S., Viertelhaus, A., Orzechowski, A., Hoogstraate, J., Gjellan, K., Schrenk, D. Kauffmann, H.-M. (2001) Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1. Toxicology, 156, 81 91.
10. Edelmann, H.M., Duchek, P., Rosenthal, F.E., Foger, N., Glackin, C., Kane, S.E. Kuchler, K. (1999) Cmdr1, a chicken P-Glycoprptein, confers multidrug resistance and interacts with estradiols. Biological Chemistry, 380, 231 241.
11. Faber, K.N., Muller, M. Jansen, P.L.M. (2003) Drug transport proteins in the liver. Advanced Drug Delivery Reviews, 55, 107 124.
12. Garcia, M.A., Solans, C., Aramayona, J.J., Rueda, S. Bregante, M.A. (2000) Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection. Biomedical Chromatography, 14, 89 92.
13. Gibaldi, M. Perrier, D. (1982) Noncompartmental analysis based on statistical moment theory. In Pharmacokinetics, 2nd edn. Ed. Dekker, M., pp. 409 417. Informa Healthcare, New York, USA.
14. Gotoh, Y., Suzuki, H., Kinoshita, S., Hirohashi, T., Kato, Y. Sugiyama, Y. (2000) Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multi-drug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats. The Journal of Pharmacology and Experimental Therapeutics, 292, 433 439.
15. Gutmann, H., Hruz, P., Zimmermann, C., Beglinger, C. Drewe, J. (2005) Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. Biochemical Pharmacology, 70, 695 699.
16. Harmsen, S., Meijerman, I., Beijnen, J.H. Schellens, J.H.M. (2007) The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology. Cancer Treatment Reviews, 33, 369 380.
17. Imai, Y., Ishikawa, E., Asada, S. Sugimoto, Y. (2005) Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Research, 65, 596 604.
18. de Lange, E.C.M., Marchand, S., van den Berga, D.-J., van der Sandt, I.C.J., de Boer, A.G., Delon, A., Bouquet, S. Couet, W. (2000) In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin. European Journal of Pharmaceutical Sciences, 12, 85 93.
19. Langmann, T., Mauerer, R., Zahn, A., Moehle, C., Probst, M., Stremmel, W. Schmitz, G. (2003) Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clinical Chemistry, 49, 230 238.
20. Lechapt-Zalcman, E., Hurbain, I., Lacave, R., Commo, F., Urban, T., Antoine, M., Milleron, B. Bernaudin, J.F. (1997) MDR1-Pgp 170 expression in human bronchus. The European Respiratory Journal, 10, 1837 1843.
21. Leonard, G.D., Fojo, T. Bates, S.E. (2003) The role of ABC transporters in clinical practice. The Oncologist, 8, 411 424.
22. Lin, J.H. Yamazaki, M. (2003) Role of P-Glycoprotein in pharmacokinetics clinical implications. Clinical Pharmacokinetics, 42, 59 98.
23. Lindecrona, R.H., Friis, C. Nielsen, J.P. (2000) Pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy and in Salmonella typhimurium infected pigs. Research in Veterinary Science, 68, 211 216.
24. Linton, K.J. (2007) Structure and function of ABC transporters. Physiology, 22, 122 130.
25. Maher, J.M., Slitt, A.L., Cherrington, N.J., Cheng, X. Klaassen, C.D. (2005) Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (MRP) family in mice. Drug Metabolism and Disposition, 33, 947 955.
26. Maliepaard, M., Scheffer, G.L., Faneyte, I.F., van Gastelen, M.A., Pijnenborg, A.C.L.M., Schinkel, A.H., van de Vijver, M.J., Scheper, R.J. Schellens, J.H.M. (2001) Subcellular localization and distribution of the Breast cancer resistance protein transporter in normal human tissues. Cancer Research, 61, 3458 3464.
27. Mealey, K.L. (2004) Therapeutic implications of the MDR-1 gene. Journal of Veterinary Pharmacology and Therapeutics, 27, 257 264.
28. Melaine, N., Lienard, M.-O., Dorval, I., Le Goascogne, C., Lejeune, H. Jegou, B. (2002) Multidrug resistance genes and P-Glycoprotein in the testis of the rat, mouse, Guinea pig, and human. Biology of Reproduction, 67, 1699 1707.
29. Miller, D.S., Nobmann, S.N., Gutmann, H., Toeroek, M., Drewe, J. Fricker, G. (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Molecular Pharmacology, 58, 1357 1367.
30. Mottino, A.D., Hoffman, T., Jennes, L. Vore, M. (2000) Expression and localization of multidrug resistant protein Mrp2 in rat small intestine. The Journal of Pharmacology and Experimental Therapeutics, 293, 717 723.
31. Naruhashi, K., Tamai, I., Inoue, N., Muraoka, H., Sai, Y., Suzuki, N. Tsuji, A. (2002) Involvement of Multidrug resistance-associated protein intestinal secretion of grepafloxacin in rats. Antimicrobial Agents and Chemotherapy, 46, 344 349.
32. Potschka, H., Fedrowitz, M. Loscher, W. (2003) Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity. The Journal of Pharmacology and Experimental Therapeutics, 306, 124 131.
33. Rabbaa, L., Dautrey, S., Colas-Linhart, N., Carbon, C. Farinotti, R. (1997) Absorption of ofloxacin isomers in the rat small intestine. Antimicrobial Agents and Chemotherapy, 41, 2274 2277.
34. Radonic, A., Thulke, S., Mackay, I.M., Landt, O., Siegert, W. Nitsche, A. (2004) Guideline to reference gene selection for quantitative real-time PCR. Biochemical and Biophysical Research Communications, 313, 856 862.
35. Ramon, J., Dautrey, S., Farinoti, R., Carbon, C. Rubinstein, E. (1994) Intestinal elimination of ciprofloxacin in rabbits. Antimicrobial Agents and Chemotherapy, 38, 757 760.
36. Rodriguez-Ibanez, M., Nalda-Molina, R., Montalar-Montero, M., Bermejo, M.V., Merino, V. Garrigues, T.M. (2003) Transintestinal secretion of ciprofloxacin, grepafloxacin and sparfloxacin: in vitro and in situ inhibition studies. European Journal of Pharmaceutics and Biopharmaceutics, 55, 241 246.
37. Sasabe, H., Kato, Y., Suzuki, T., Itose, M., Miyamoto, G. Sugiyama, Y. (2004) Differential involvement of Multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice. The Journal of Pharmacology and Experimental Therapeutics, 310, 648 655.
38. Schaub, T.P., Kartenbeck, J., Konig, J., Spring, H., Dorsam, J., Staehler, G., Storkel, S., Thon, W.F. Keppler, D.J. (1999) Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. Journal of the American Society of Nephrology: JASN, 10, 1159 1169.
39. Scheffer, G.L., Pijnenborg, A.C., Smit, E.F., Muller, M., Postma, D.S., Timens, W., van der Valk, P., de Vries, E.G. Scheper, R.J. (2002) Multidrug resistance related molecules in human and murine lung. Journal of Clinical Pathology, 55, 332 339.
40. Schinkel, A.H., Smit, J.J.M., van Tellingen, O., Beijnen, J.H., Wagnaar, E., van Deemter, L., Mol, C.A.A.M., van der Valk, M.A., Robanus-Maandag, E.C., te Riele, H.P.J., Berns, A.J.M. Borst, P. (1994) Disruption of the mouse mdr 1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77, 491 502.
41. Schrickx, J.A. Fink-Gremmels, J. (2007) Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters. British Journal of Pharmacology, 150, 463 469.
42. Stephens, R.H., Tanianis-Hughes, J., Higg, N.B., Humphrey, M. Warhurst, G. (2002) Region-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdra (-/-) mouse intestine. The Journal of Pharmacology and Experimental Therapeutics, 303, 1095 10101.
43. Taipalensuu, J., Törnblom, H., Lindberg, G., Einarsson, C., Sjöqvist, F., Melhus, H., Garberg, P., Sjöström, B., Lundgren, B. Artursson, P. (2001) Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. The Journal of Pharmacology and Experimental Therapeutics, 299, 164 170.
44. Tanaka, Y., Slitt, A.L., Leazer, T.M., Maher, J.M. Klaassen, C.D. (2005) Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochemical and Biophysical Research Communications, 326, 181 187.
45. Tang, H., Pak, Y. Mayersohn, M. (2004) Protein expression pattern of P-Glycoprotein along the gastrointestinal tract of the Yucatan micropig. Journal of Biochemical and Molecular Toxicology, 18, 18 22.
46. Thörn, M., Finnström, N., Lundgren, S., Rane, A. Lööf, L. (2005) Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. British Journal of Clinical Pharmacology, 60, 54 60.
47. Torky, A.-R.W., Stehfest, E., Viehweger, K., Taege, C. Foth, H. (2005) Immuno-histochemical detection of MRPs in human lung cells in culture. Toxicology, 207, 437 450.
48. Trezise, A.E.O., Romano, P.R., Gill, D.R., Hyde, S.C., Seulveda, F.V., Buchwald, M. Higgins, C.F. (1992) The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. The EMBO Journal, 11, 4291 4303.
49. Vandesompele, J., De Peter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology, 3, research0034.1 0034.11.
50. Wang, H., Liao, Z.-X., Chen, M. Hu, X.-L. (2006) Effects of hepatic fibrosis on ofloxacin pharmacokinetics in rats. Pharmacological Research, 53, 28 34.
51. Xu, C., Li, C.Y.-T. Kong, A.-N.T. (2005) Induction of phase I, II and III drug metabolism/transport by xenobiotics. Archives of Pharmacal Research, 28, 249 268.
52. Yamaguchi, H., Yano, I., Saito, H. Inui, K. (2002) Pharmacokinetic role of Pglycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo. The Journal of Pharmacology and Experimental Therapeutics, 300, 1063 1069.
53. Zamek-Gliszczynski, M.J., Hoffmaster, K.A., Nezasa, K., Tallman, M.N. Brouwer, K.L.R. (2006) Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. European Journal of Pharmaceutical Sciences, 27, 447 486.
54. Zhang, Y., Han, H., Elmquist, W.F. Miller, D.W. (2000) Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Research, 876, 148 153.
55. Zhao, Y.L., Cai, S.H., Wang, L., Kitaichi, K., Tatsumi, Y., Nadai, M., Yoshizumi, H., Takagi, K., Takagi, K. Hasegawa, T. (2002) Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin. Clinical and Experimental Pharmacology & Physiology, 29, 167 172.
56. Zimmermann, C., Gutmann, H., Hruz, P., Gutzwiller, J.-P., Beglinger, C. Drewe, J. (2005) Mapping of multidrug restance gene 1 and multidrug restanceassociated protein isoform 1 to 5 mRNA expression along the human intestinal tract. Drug Metabolism and Disposition, 33, 219 224.